GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: example 77 [WO2024095133]
Compound class:
Synthetic organic
Comment: The chemical structure for balumorexton was obtained from WHO INN proposed list 134 (Feb 2026), in which it is described as an orexin receptor agonist and potential narcolepsy therapeutic. The structure is claimed in Takeda patent WO2024095133 [1]. At time of curation (Feb 2026) Takeda's declared development pipeline contained two OX2 receptor agonists, oveporexton (TAK-861) and TAK-360, so balumorexton is likely the INN for the latter candidate. Balumorexton is a benzisoxazole-containing compound.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| N-[(6R)-7,7-difluoro-2-[5-fluoro-4-(2,4,6-trifluorophenyl)-1,2-benzoxazol-3-yl]-3-oxo-5,6-dihydropyrrolo[1,2-c]imidazol-6-yl]methanesulfonamide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13904 | balumorexton |
Synonyms ![]() |
| example 77 [WO2024095133] |
Database Links ![]() |
|
| CAS Registry No. | 3037907-48-2 (source: WHO INN record) |
| PubChem CID | 171548344 |
| Search Google for chemical match using the InChIKey | QYIMOBVUEGPQSO-CYBMUJFWSA-N |
| Search Google for chemicals with the same backbone | QYIMOBVUEGPQSO |
| Search PubMed clinical trials | balumorexton |
| Search PubMed titles | balumorexton |
| Search PubMed titles/abstracts | balumorexton |
| UniChem Compound Search for chemical match using the InChIKey | QYIMOBVUEGPQSO-CYBMUJFWSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | QYIMOBVUEGPQSO-CYBMUJFWSA-N |